Boston Capital Investment Club

BIO International Global Forum Topics： - International Collaboration for BD - NewCo Deals - Trends in Dollar Fund Investments - Cooperation with Chinese?Biopharmaceutical companies Register before April 1st to enjoy early bird discount. 20% discount for registrations before February 1, 2025:?Discount Code: DSJ71neS 10% discount for registrations before April 1, 2025:?Discount Code: DS38o3QY Exclusive Registration Channel for BCIC: https://lnkd.in/e6Y6BiEn For more information, please follow the below link. https://lnkd.in/eAmkqVXy

Join us for an exclusive fireside chat with three standout finalists from the 2024 awards! Hear their journeys firsthand—how they built their startups, overcame challenges, and secured (or are to secure) funding. Don’t miss this chance to gain insights and inspiration from rising industry leaders! Date: Feb 26th 8-9pm EST / Feb 27th 9-10am HKT Format: Online, please click the link below for registration, we will email you with the zoom link. If you do not receive an email with a link, please check your spam folder. https://lnkd.in/dZaKik9Z For more information, please check below link https://lnkd.in/dk3X5TKu

You are invited to the 2025 Biomedical Pitch Competition, connecting biomedical start-ups with investors and other business accelerator resources. Please submit your applications by?March 31st, 2025.?All biomedical startups from concept to pre-IPO are welcome to participate. Benefits of Firms Participating in Pitch Competition? -$100+ mil raised from participant firms in the last three years? –Potential direct equity investment?from?200+ Angel/VC funds/MNCs -Many top-tier VCs & MNCs serve as final judges –Fundraising, License Out or NewCo?opportunities for your technology -Partnership opportunities from venture capitalists, serial entrepreneurs, corporate executives, and attorneys -Media exposure through partners’ networks. (20k+ views) History of accomplishments 2024 Pitch Competition Accomplishments – Rapafusyn raised $28 million successfully in USA? (https://lnkd.in/eehSuEQR) – Agilis secured $10 million successfully from a Singapore family office (https://lnkd.in/eRqFerYC) 2023 Pitch Competition Accomplishments – Myrobalan raised $24 million successfully in the US within 5 months after participating in the pitch competition. (https://lnkd.in/ehX7x6Jd) – Two startups raised $1mil and $2mil separately. 2022 Pitch Competition Accomplishments – Amytrx has raised $18 million – ARIZ Precision Medicine has raised $3 million – Biostage has raised $5 million. Timeline: The deadline for registration is?March 31st, 2025 Preliminary Pitches: April, 2025 Semi Final Pitches：May, 2025 Final Contest: June, 2025 For more information please follow the link https://lnkd.in/eAFtZSFa Please register using the link below https://lnkd.in/esXZNDYt

????2nd?Innovation in Women’s Health Pitch Competition???? We’re bringing together passionate innovators, investors, and experts to push the boundaries of women’s health! ?? This is your chance to be a part of something big—network with like-minded individuals, discover groundbreaking ideas, and cast your vote to help choose the next big winner in women’s health innovation! ?? Your vote could shape the future of healthcare and make a real impact.? Don’t miss this incredible opportunity to be part of the change! Let’s make a difference together! ?? #InnovationInWomensHealth #PitchCompetition #VoteForChange #HealthInnovation #WomensHealthMatters MyPhuong Le, PhD Leah Villegas, PhD, MBA Eric Westreich Emith Lopez Ron D. Daniel Wege Alaleh Golkar Narenji, PhD

We’ve just updated our Page. It is officially named as Boston Capital Investment Club. Visit our Page to see the latest updates.

Congratulation on Rapafusyn Pharmaceuticals for raising $28 milllion successfully in its series A funding round. Rapafusyn Pharmaceuticals was awarded with Third Prize award in 2024 Biomedical Pitch Competition organized by Boston Chinese Investment Club （BCIC）and Hong Kong Science and Technology Parks Corporation (HKSTP（https://lnkd.in/ecSTqXDb the following was officially released news from AP https://lnkd.in/e6jkFBmu Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform BY?RAPAFUSYN PHARMACEUTICALS Published 10:47 AM EDT, June 20, 2024 Rapafusyn’s RapaGlue? platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging or previously undruggable disease targets Financing led by 3E Bioventures Capital and Proxima Ventures Ltd. with participation from Lapam Capital Founded by Professor Jun O. Liu of Johns Hopkins University School of Medicine, a pioneer in the molecular glue field https://lnkd.in/eNQNufwK

Congratulation on Agilis for raising $10 milllion successfully in its A+ funding round. Agilis was awarded with innovation award in 2024 Biomedical Pitch Competition organized by Boston Chinese Investment Club （BCIC）and Hong Kong Science and Technology Parks Corporation (HKSTP) https://lnkd.in/e3yucKDu following is official news released in?thestandard.com Robotics start-up secures US$10m funding Hong Kong startup Agilis Robotics, a spin-off from The Hong Kong University, secured US$10 million (HK$78 million) through its A+ funding round. It develops robotic instruments to optimize surgical efficiency, and plans to conduct trials in mainland hospitals, paving the way for NMPA and FDA approval and commercialization. The surgical robotics startup made technological breakthroughs in developing highly miniaturized and flexible robotic instruments to offer surgeons exceptional dexterity even in the most challenging anatomies, according to the company. Most of their managers, members and partners are from HKU and The Chinese University of Hong Kong. The company is supported by the Hong Kong Government under Innovation and Technology Commission funding. Its goal is to develop minimally invasive robotic instruments with artificial intelligence technology to provide clinicians with early-stage cancer care. https://lnkd.in/e7g8K3Hj

2024 Biomedical Pitch Competition Grand Finale?Successfully Concludes We are excited to bring you the grand finale recap of the 2024 Biomedical Pitch Competition, which took place on April 27th at Simcere Boston Innovation Center in Cambridge Discovery Park. This event marked a milestone in the biomedical industry, showcasing the brightest minds and most innovative technologies. A Meeting of Minds and Innovation The 2024 Biomedical Pitch Competition, co-organized by the Hong Kong Science and Technology Parks Corporation (HKSTP) and the Boston Chinese Investment Club (BCIC), featured 14 high-caliber teams from the biomedical sector in the final round. These finalists, ranging from early to mid-stage ventures in pharmaceuticals, medical devices, and diagnostics, had the opportunity to present their transformative ideas to a distinguished panel of judges and an audience of industry leaders, investors, and media. We were honored to have Dr. Grace Lau, Head of Institute for Translational Research?and Dr. Weng-Li Yoon, Associate Director, Therapeutics?from HKSTP, along with Dr. Qiusong Tang from Roche Accelerator, deliver inspiring keynote addresses. Their speeches highlighted the ongoing efforts and commitments toward accelerating biomedical innovation and fostering a supportive ecosystem for emerging technologies in healthcare. Our panel of judges included representatives from HKSTP, Roche Accelerator, Kendall Capital Partners, PagodaTree Partners, and LB Ventures. Their deep industry knowledge and critical insights were crucial in selecting the winners among many impressive contenders. Extensive live coverage by leading media partners such as?深蓝观,?赛柏蓝, E药经理人,?药时代, Gene Online, and Page Executive ensured that the event received global attention. Celebrating the Winners The competition was fierce, and the innovation displayed was nothing short of remarkable. Congratulations to the winners of this final round: First Prize GV20 Therapeutics Second Prize Affinity Biopharma Axcynsis Therapeutics Third Prize ImmVira Group: A Novel Payload Deliver Rapafusyn Pharmaceuticals Cure Genetics Inc. D2M Biotherapeutics Innovation Award Leveragen, Inc. f5 Therapeutics Incorporated Agilis Robotics Limited Spark Spine Azura Bio, Inc. AI-powered Painless Blood Test Device NeuronOff, Inc. Looking ahead The success of the 2024 Biomedical Pitch Competition underscores the vibrant potential of the biomedical sector and its significant role in shaping the future of healthcare, attracting more than 17,000 active international viewers through live-streaming portals. We extend our heartfelt congratulations to all participants and winners who have set new benchmarks in innovation. Stay connected for more updates and breakthroughs from around the world! More about the organizer: Hong Kong Science and Technology Parks Corporation: www.hkstp.org. Boston Chinese Investment Club: https://bcicglobal.org https://lnkd.in/eVwQy8WN

#biotech #pitch #biomedical #startups #vc #Boston We would like to invite you to the 2024 Biomedical Pitch Competition,?connecting?biomedical?start-ups?with?investors?and?other?business?accelerator?resources.?12?selected?high-quality?teams, ranging?from?early-stage?to?mid-stage?and?from?pharmaceutic?to?medical?device?and?diagnostics,?will?present?their?companies?in?public. Semifinal and Final competition will be held on April 27th, 2024, from 9am to 5pm. Location: Sincere, 20 Acorn Park Dr., 2nd Floor, Cambridge, MA 02140 Registration link: https://lnkd.in/e8wMAGw3 Registration QR code can be found in the last picture.

2024 Biomedical Final Pitch Competition Co-organizers:? Boston Chinese Investment Club (BCIC) Hong Kong Science and Technology Parks Corporation (HKSTP)